Enlivex Therapeutics
ENLV
ENLV
9 hedge funds and large institutions have $211K invested in Enlivex Therapeutics in 2017 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 4 closing their positions.
Holders
9
Holders Change
-2
Holders Change %
-18.18%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Renaissance Technologies
New York
|
$139K |
| 2 |
WS
2
Wedbush Securities
Los Angeles,
California
|
$25K |
| 3 |
TSS
3
Two Sigma Securities
New York
|
$9K |
Top Sellers
| 1 |
SM
1
Sabby Management
Miami Beach,
Florida
|
$0 |
| 2 |
2
BlackRock
New York
|
$0 |
| 3 |
3
Citadel Advisors
Miami,
Florida
|
$0 |
| 4 |
FPF
4
FNY Partners Fund
New York
|
$0 |
| 5 |
VKH
5
Virtu KCG Holdings
New York
|
$8K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $139K | 207,700 | +48,400 | +30% |
|
|
WS
2
Wedbush Securities
Los Angeles,
California
| $25K | 37,500 | +22,500 | +150% |
|
3
HighTower Advisors
Chicago,
Illinois
| $17K | 24,000 | – | – |
|
|
TSS
4
Two Sigma Securities
New York
| $9K | 12,748 | +12,748 | New |
|
|
VKH
5
Virtu KCG Holdings
New York
| $8K | 11,468 | -15,495 | -57% |
|
|
OC
6
Oppenheimer & Co
New York
| $8K | 13,100 | -1,200 | -8% |
|
7
UBS Group
Zurich,
Switzerland
| $4K | 6,200 | -3,018 | -33% |
|
|
LTFS
8
Ladenburg Thalmann Financial Services
Miami,
Florida
| $1K | 1,000 | – | – |
|
|
SM
9
Sabby Management
Miami Beach,
Florida
| – | – | -219,905 | Closed |
|
|
10
Citadel Advisors
Miami,
Florida
| – | – | -22,793 | Closed |
|
|
11
BlackRock
New York
| – | – | -22,471 | Closed |
|
|
FPF
12
FNY Partners Fund
New York
| – | – | -18,000 | Closed |
|
13
Morgan Stanley
New York
| $0 | 713 | +713 | New |
|